drugset / Trial / NCT03492268
Safety and Efficacy Evaluation of BCMA-CART for Treating Multiple Myeloma
Withdrawn
Bioray Laboratories
Second Xiangya Hospital of Central South University · collabThe First Affiliated Hospital of Zhengzhou University · collab
NaSingle-groupOpen-labelTreatment
Summary
This trial aims to evaluate the safety and efficacy of BCMA-CART in treating patients with relapsed or refractory multiple myeloma.
Timeline
- Start
- 2021-11-01
- Primary completion
- 2022-12
- Completion
- 2024-12
Outcome
Outcome not reported
Stopped: “Due to CART processing facility construction”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BCMA CAR-T | Cell therapy | — | — |